Natural Phenomenon or Process – Page 3

Inventiva Slashes Workforce and Pipeline to Focus on MASH Drug Lanifibranor

2 months ago talkbio0Tagged Inventiva, lanifibranor, MASH, Phase 3 trial, pipeline, restructuring

Inventiva, layoffs, pipeline reduction, lanifibranor, MASH, Phase 3 trial, biotech restructuring

ViiV Healthcare’s Multifaceted Approach to Combating HIV in Black Communities

3 months ago talkbio0Tagged Black Populations, care activity, Community, community grants, HIV Prevention, Indication of (contextual qualifier), Risk, Social stigmata, ViiV Healthcare

ViiV Healthcare, HIV prevention, Black communities, Risk to Reasons, community grants, stigma reduction, education, access to care

X4 Pharmaceuticals Restructures to Advance Mavorixafor for Chronic Neutropenia and Optimize XOLREMDI Promotion

3 months ago talkbio0Tagged Antagonist muscle action, Chronic neutropenia, CXCR4 gene, strategic, WHIM syndrome, Xolremdi

X4 Pharmaceuticals, mavorixafor, XOLREMDI, CXCR4 antagonist, WHIM syndrome, chronic neutropenia, workforce reduction, strategic restructuring

Trump Administration Targets Massive Cuts to Federal Health Workforce

3 months ago talkbio0Tagged Administration occupational activities, CHARGE Syndrome, federal, Government, health workers, healthcare agencies, Transplant Registry Unified Management Program, United States Food and Drug Administration

federal health workers, layoffs, Trump administration, HHS, FDA, healthcare agencies, workforce reduction, government downsizing

Pharmaceutical Giants Bristol Myers Squibb and Kyowa Kirin Announce 119 Layoffs in New Jersey Amid Restructuring Efforts

3 months ago talkbio0Tagged cost-cutting, Drug Industry, Kirin, Kyowa, Myers, New Jersey, restructuring, squibb

Bristol Myers Squibb, Kyowa Kirin, layoffs, New Jersey, restructuring, pharmaceutical industry, cost-cutting, workforce reduction

Bristol Myers Squibb and Kyowa Kirin Announce New Rounds of Layoffs in New Jersey

3 months ago talkbio0Tagged cost-cutting measures, Jersey pharma, Kirin, Kyowa, Myers, Pharmaceutical Layoffs, squibb

Pharmaceutical layoffs, workforce reduction, cost-cutting measures, Bristol Myers Squibb, Kyowa Kirin, New Jersey pharma industry

Thermo Fisher Scientific Continues Workforce Reduction with 300 Layoffs in Massachusetts

3 months ago talkbio0Tagged Biotechnology, cost-cutting measures, Industry, Massachusetts (geographic location), Thermo Fisher Scientific, Viral Vector

Thermo Fisher Scientific, layoffs, Massachusetts, viral vector production, workforce reduction, biotechnology industry, cost-cutting measures

Stoke Therapeutics Announces Global Phase 3 EMPEROR Study Design for Zorevunersen in Dravet Syndrome

3 months ago talkbio0Tagged Clinical Research, Cognitive Improvement, EMPEROR, Infantile Severe Myoclonic Epilepsy, Phase 3 trial, regulatory, Seizures, Zorevunersen

Dravet syndrome, zorevunersen, Phase 3 trial, EMPEROR study, seizure reduction, cognitive improvement, regulatory alignment

Secretary Rubio Expands Humanitarian Exemptions in US Foreign Aid Freeze

3 months ago talkbio0Tagged Freezing, global health programs, Humanitarian Exemptions, International Aspects, Manufactured Supplies, Marco Rubio, United States Agency for International Development

Marco Rubio, foreign aid freeze, humanitarian exemptions, USAID, medicine supplies, global health programs

Allakos Discontinues AK006 Development, Cuts 75% of Workforce Amid Strategic Restructuring

3 months ago talkbio0Tagged AK006, Allakos, Biotechnology, Chronic Spontaneous Urticaria, Failure (biologic function), Financial cost, phase 1 trial, restructuring, strategic alternatives

Allakos, AK006, workforce reduction, strategic alternatives, Phase 1 trial failure, chronic spontaneous urticaria (CSU), biotechnology, restructuring costs.